Humans Klebsiella pneumoniae Meropenem / pharmacology beta-Lactamases / metabolism Microbial Sensitivity Tests Azabicyclo Compounds / pharmacology Ceftazidime / pharmacology Anti-Bacterial Agents / pharmacology beta-Lactamase Inhibitors / pharmacology Cephalosporins / pharmacology Carbapenems / pharmacology Escherichia coli Drug Combinations Imipenem / pharmacology Klebsiella Infections Bacterial Proteins / metabolism
KPC Klebsiella pneumoniae antibiotic resistance carbapenemase imipenem-relebactam resistance

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
18 10 2022
Historique:
pubmed: 27 9 2022
medline: 21 10 2022
entrez: 26 9 2022
Statut: ppublish

Résumé

Carbapenem-resistant

Identifiants

DOI: 10.1128/aac.00918-22 PMID: 36154170 PMC: PMC9578389
pubmed: 36154170
doi: 10.1128/aac.00918-22
pmc: PMC9578389
doi:

Substances chimiques

relebactam Y1MYA2UHFL
Meropenem FV9J3JU8B1
beta-Lactamases EC 3.5.2.6
Azabicyclo Compounds 0
Ceftazidime 9M416Z9QNR
Anti-Bacterial Agents 0
beta-Lactamase Inhibitors 0
Cephalosporins 0
Carbapenems 0
Drug Combinations 0
Imipenem 71OTZ9ZE0A
Bacterial Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0091822

Références

Clin Microbiol Rev. 2020 Nov 11;34(1):
pubmed: 33177185
Antimicrob Agents Chemother. 2019 Sep 23;63(10):
pubmed: 31332070
Antimicrob Agents Chemother. 2019 Sep 16;:
pubmed: 31527032
J Antimicrob Chemother. 2018 Mar 1;73(3):648-657
pubmed: 29228202
Antimicrob Agents Chemother. 2020 Jul 22;64(8):
pubmed: 32457107
Nat Commun. 2019 Sep 2;10(1):3957
pubmed: 31477712
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Antibiotics (Basel). 2021 Aug 17;10(8):
pubmed: 34439045
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 29038260
J Med Microbiol. 2009 Oct;58(Pt 10):1303-1308
pubmed: 19556371
Euro Surveill. 2019 May;24(19):
pubmed: 31088601
PLoS Pathog. 2019 Mar 15;15(3):e1007218
pubmed: 30875398
Antimicrob Agents Chemother. 2015 Sep;59(9):5324-30
pubmed: 26100712
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28848018
J Antimicrob Chemother. 2022 May 29;77(6):1570-1577
pubmed: 35373297
Microb Drug Resist. 2018 Sep;24(7):877-881
pubmed: 29782237
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0057421
pubmed: 34339281
Clin Microbiol Infect. 2022 May;28(5):749-751
pubmed: 35124257
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28031201
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30578403
Antimicrob Agents Chemother. 2015 Oct;59(10):6605-7
pubmed: 26195508
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630202
Clin Microbiol Infect. 2017 Jan;23(1):48.e9-48.e16
pubmed: 27642178
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Biol Chem. 2012 Sep 14;287(38):31783-93
pubmed: 22843686
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0089021
pubmed: 34228551

Auteurs

Jacqueline Findlay (J)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
ORCID: 0000-0002-7335-9001

Céline Rens (C)

Clinical Microbiology Unit, Pasteur Institute of Lille, Lille, France.
European Institute for Emerging Antibiotic Resistance, Pasteur Institute and University of Lille, Lille, France.

Laurent Poirel (L)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
European Institute for Emerging Antibiotic Resistance, Pasteur Institute and University of Lille, Lille, France.
European Institute for Emerging Antibiotic Resistance, University of Fribourggrid.8534.a, Fribourg, Switzerland.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourggrid.8534.a, Fribourg, Switzerland.
INSERM European Unit (IAME, France), University of Fribourggrid.8534.a, Fribourg, Switzerland.
ORCID: 0000-0001-5160-5286

Patrice Nordmann (P)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
European Institute for Emerging Antibiotic Resistance, Pasteur Institute and University of Lille, Lille, France.
European Institute for Emerging Antibiotic Resistance, University of Fribourggrid.8534.a, Fribourg, Switzerland.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourggrid.8534.a, Fribourg, Switzerland.
INSERM European Unit (IAME, France), University of Fribourggrid.8534.a, Fribourg, Switzerland.
Institute for Microbiology, University of Lausanne and University Hospital Centre, Lausanne, Switzerland.
ORCID: 0000-0002-1343-1622

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains ›
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Klebsiella › Klebsiella pneumoniae ›
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › Thiénamycine › Méropénème ›
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases ›
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne ›
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques, cycle ponté › Composés hétérocycliques bicycliques › Composés azabicycliques ›
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › Céfaloridine › Ceftazidime ›
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens ›
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Inhibiteurs des bêta-lactamases ›
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines ›
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes ›
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli ›
questionsmedicales.fr › Préparations pharmaceutiques › Association médicamenteuse ›
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › Thiénamycine › Imipénem ›
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Infections à Klebsiella ›
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes ›